Trials / Completed
CompletedNCT05073601
Thyroid Gland Dysfunction and Vitamin D Polymorphism in Keratoconus
Thyroid Gland Dysfunction and Vitamin D Receptor Polymorphism in Keratoconus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 262 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This prospective study the thyroid gland dysfunction and vitamin D receptor polymorphism in keratoconus patients
Detailed description
This is a prospective observational study in which blood samples are collected from keratoconus patients looking for thyroid dysfunction and vitamin D levels in the serum and assessing the Vitamin D receptor polymorphism in comparison to healthy control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ELISA,DNA extraction | quantitative measurement of (Thyroid stimulating hormon (TSH), free triiodothyronine (FT3)\& Free tetraiodothyronine(FT4)) measured using ELISA . Serum 25-OH vitamin D measured using ELISA. Serum 25-OH vitamin D will be classified based on 2012 American Endocrine Society guidelines into deficient (\< 20ng/ml), insufficient ( 21 -30 ng/ml) and sufficient (\> 30 ng/ml).vitamin D receptor polymorphisms was done in 3 steps: a) DNA extraction from whole blood using Gene Jet gene DNA Purification kits . b) PCR: three Vitamin D receptor polymorphisms were tested \[Taq I (restriction enzymes according to single nucleotide polymorphism ) (rs731236), Apa I (rs7975232) and Bsm I (rs1544410)\] using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Genomic DNA was amplified using certain primers |
Timeline
- Start date
- 2021-03-06
- Primary completion
- 2021-07-01
- Completion
- 2021-09-01
- First posted
- 2021-10-11
- Last updated
- 2021-10-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05073601. Inclusion in this directory is not an endorsement.